GlassScriptPhysician profile
Katherine Mccormick
NPI 1093147241
$8,089.37
in general payments reported to CMS, 2019-2025
20 companies · $232 in 2025
The $232 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $61.78 · 2020: $11.13 · 2021: $6,597 · 2022: $125 · 2023: $557 · 2024: $506 · 2025: $232.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,294.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,294.33 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $6,646.51 | 2019-2021 | |
| Abbvie INC. | $166.72 | 2019-2023 | |
| Bayer Healthcare Pharmaceuticals INC. | $156.34 | 2022-2024 | |
| Astellas Pharma US INC | $144.71 | 2023-2025 | Veozah |
| Sumitomo Pharma America, INC. | $132.21 | 2024 | Myfembree, Gemtesa |
| Femselect INC. | $128.70 | 2023-2024 | Enplace |
| Hologic Sales and Service, LLC | $100.83 | 2023-2024 | Acessa Provu System, Novasure, Aptima |
| Daiichi Sankyo INC. | $97.38 | 2022-2024 | Injectafer |
| Organon LLC | $89.65 | 2023-2025 | Nexplanon, Nuvaring |
| Exeltis, USA INC. | $79.77 | 2024-2025 | Slynd |
| Caldera Medical, INC | $78.87 | 2023 | Desara |
| Biogen, INC. | $76.24 | 2024-2025 | Zurzuvae |
| Coloplast Corp | $56.15 | 2023 | Saffron |
| Merck Sharp & Dohme LLC | $43.99 | 2024-2025 | Gardasil 9, Gardasil |
| Coopersurgical, INC. | $19.43 | 2025 | Paragard T 380a |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Shield Therapeutics INC | $16.63 | 2023 | Accrufer |
| Smith+Nephew, INC. | $15.61 | 2025 | Pico 7 |
| Meditrina | $13.51 | 2023 | |
| Minerva Surgical, INC | $13.47 | 2023 | |
| Aspira Women'S Health INC | $12.65 | 2024 | Ova1 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Katherine Mccormick listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.